Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Here are highlights from the July issue of Mayo Clinic Women's HealthSource. You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required.

20 Jul 2010

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Kidney disease is a growing public health problem, with approximately half a million individuals in the United States requiring dialysis treatments to replace the function of their failed kidneys. The problem is particularly acute among African-Americans, whose rates of kidney disease are four times higher than those of European Americans.

20 Jul 2010

Researchers identify a mechanism that explains different phases of CML progression

Researchers at Duke University Medical Center have identified a mechanism that could explain how patients move into the worst phase of chronic myelogenous leukemia.

20 Jul 2010

Researchers monitor stress during a real-time war to refine PTSD therapy

Psychologists aren't usually called to the battlefield, but the 2008-09 Gaza War gave Tel Aviv University researchers a unique picture of how anxiety manifests during stressful situations.

20 Jul 2010

Robotic therapies reduce blood vessel trauma during minimally invasive procedures

Research conducted by surgeons from the Methodist DeBakey Heart & Vascular Center shows that using robotics reduces blood vessel trauma during minimally invasive procedures to repair diseased arteries. Research results were presented at the Society for Vascular Surgery's 2010 Vascular Annual Meeting in Boston.

19 Jul 2010

Eisai's NDA for BANZEL Oral Suspension accepted for FDA review

Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's NDA for BANZEL® (rufinamide) Oral Suspension (40 mg/mL).

19 Jul 2010

Visage Imaging releases Amira 5.3 single platform brain imaging tool

Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd., is pleased to announce the immediate release of Amira 5.3, a new major version of its market-leading software platform for visualizing, analyzing, and presenting complex 3D and 4D biomedical data.

19 Jul 2010

Brain cancer survivor completes journey across America to raise awareness, money for brain cancer research

Anne Feeley, a 56-year-old mother and brain cancer survivor, completed her journey across America today, cycling 3,708 miles, to raise awareness and money for brain cancer research and patient care. Feeley pedaled the last 6.5 miles of her journey from Hains Point, VA to cross the finish line at the Capital Reflecting Pool in Washington, DC.

19 Jul 2010

Olig1 and Olig2 genes are associated with Down syndrome, scientists identify

Down syndrome is a well known cause of mental retardation and other medical problems, including early onset of Alzheimer disease. It has long been known that Down syndrome is associated with an individual having an additional copy of chromosome 21. Research findings reported in the July 18 advanced online publication of Nature Neuroscience have narrowed down the critical genetic elements responsible for some aspects of Down syndrome.

19 Jul 2010

Over 50% of neurosurgical procedures performed on Afghan children were for battlefield-related injuries

War inevitably takes a tragic toll on innocent bystanders including civilians and children. Military neurosurgeons have a long history of helping US and coalition troops and civilians overcome devastating and life-threatening neurological injuries incurred as a result of military strife. While stationed at US military facilities, neurosurgeons also contribute to invaluable humanitarian efforts, operating on patients with injuries and conditions unrelated to battle.

17 Jul 2010

Species with larger brains live longer

"In the past, it was thought that one of the selective advantages of having a large brain is that it facilitates the development of new behaviour to respond to the ecological challenges that the individual has not experienced before, such as a sudden reduction in food or the appearance of a new predator ", C-sar Gonz-lez-Lagos, main author of the study and researcher at the Centre of Ecological Research and Forestry Applications (CREAF) associated with the Autonomous University of Barcelona, highlights to SINC.

17 Jul 2010

Relationship between music, neurosciences to be discussed in a conference at Edinburgh

The Mariani Foundation for Paediatric Neurology announces "The Neurosciences and Music - IV: Learning and Memory", to be held in Edinburgh (Scotland, UK) from 9th to 12th June 2011. The conference is conceived as a continuation of the previous meetings on the relation between music and the neurosciences in which our foundation participated: "The Biological Foundations of Music" (New York, 2000), "The Neurosciences and Music, Mutual Interactions and Implications of Developmental Functions" (Venice, 2002), "The Neurosciences and Music - II, From Perception to Performance" (Leipzig, 2005) and "The Neurosciences and Music - III, Disorders and Plasticity".

17 Jul 2010

GABA disrupts working memory in neurofibromatosis type 1 patients

Imagine if your brain lost its working memory - the ability to hold and manipulate information in your mind's eye. That's the plight faced by millions of people with neurofibromatosis type 1, or NF1. The genetic condition affects one in 3,500 people and is the most common cause of learning disabilities.Now a UCLA research team has uncovered new clues about how NF1 disrupts working memory. Published in the July 12 online edition of Proceedings of the National Academy of Sciences, the findings suggest a potential drug target for correcting NF1-related learning disabilities.

17 Jul 2010

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

As a national research university, Florida Institute of Technology not only involves its students in research, but also seeks to license and patent its many innovations. An example of recently licensed university technology is a chemical compound that facilitates the work of neuroscientists in the laboratory.Associate Professor Nasri Nesnas was familiar as a chemist with the chemical compound CDNI-Glu, a commonly used laboratory research tool. Most often, neuroscientists use it to study the brain's neural networks by improving the localization of synaptic stimulation

17 Jul 2010

Cage type affects laboratory mice brain

Researchers at the University of Colorado's Anschutz Medical Campus have found the brains of mice used in laboratories worldwide can be profoundly affected by the type of cage they are kept in, a breakthrough that may require scientists to reevaluate the way they conduct future experiments.

17 Jul 2010

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.

17 Jul 2010

Impact of circadian dysregulation on mental, physical health

Circadian (daily) rhythms are found in all functions - e.g. performance, mood, endocrine rhythms, behaviour, sleep timing. The biological clocks that control circadian rhythms are based on a genetic programme of interacting molecules in cells throughout the body, coordinated by a ´master clock´ in the brain and synchronised by external cues, mainly light.

16 Jul 2010

All dementia isn't Alzheimer's disease: Mayo Clinic

Occasional misplaced keys or forgotten names don't mark the beginning of dementia. All dementia isn't Alzheimer's disease. Some dementia symptoms can be reversed. Those facts and many more are covered in Deciphering Dementia, a supplemental Special Report to the July issue of Mayo Clinic Women's HealthSource

16 Jul 2010

Brain imaging studies can provide biomarkers for depression diagnosis: Study

Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.

16 Jul 2010

Two-thirds of world's population are vitamin D-insufficient or deficient

Vitamin D surfaces as a news topic every few months. How much daily vitamin D should a person get? Is it possible to have too much of it? Is exposure to the sun, which is the body's natural way of producing vitamin D, the best option? Or do supplements suffice?

16 Jul 2010

Brain News and Research

Further Reading

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Researchers identify a mechanism that explains different phases of CML progression

Researchers monitor stress during a real-time war to refine PTSD therapy

Robotic therapies reduce blood vessel trauma during minimally invasive procedures

Eisai's NDA for BANZEL Oral Suspension accepted for FDA review

Visage Imaging releases Amira 5.3 single platform brain imaging tool

Brain cancer survivor completes journey across America to raise awareness, money for brain cancer research

Olig1 and Olig2 genes are associated with Down syndrome, scientists identify

Over 50% of neurosurgical procedures performed on Afghan children were for battlefield-related injuries

Species with larger brains live longer

Relationship between music, neurosciences to be discussed in a conference at Edinburgh

GABA disrupts working memory in neurofibromatosis type 1 patients

Florida Institute of Technology assists licensing CDNI-Glu compound to UK company

Cage type affects laboratory mice brain

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

Impact of circadian dysregulation on mental, physical health

All dementia isn't Alzheimer's disease: Mayo Clinic

Brain imaging studies can provide biomarkers for depression diagnosis: Study

Two-thirds of world's population are vitamin D-insufficient or deficient

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News